depression to show homicidal behaviour towards close relatives, particularly in a suicide pact, has been underestimated-at least in the United States.
Yet the small numbers, the scanty information, and the fact that other motives operate in some pacts counsel caution before this view is adopted. Five of Cohen's examples had no aggressive element but were lovers' pacts (though in one of these the man did not want to die).5 Elsewhere he states: "the decision as a rule is mutual." Stengel agrees: "the notes left behind nearly always state that the decision was evenly shared"; but he adds significantly: "the initiative usually comes from one of the two and sometimes a good deal of persuasion has to be used."6 In the recent deaths of Arthur Koestler and his wife what must have seemed to be a pact turned out more probably to have been the result of two independent decisions.7
Even if he errs by underestimating the variety of suicide pacts, Rosenbaum's paper is welcome. He is justified in reminding doctors that in those who suffer from severe depression their aggressive as well as their suicidal potential needs assessing. ALAN 
Referral of chronic arthritics
Chronic inflammatory arthritis affects 1-2% of the adult population and many of these patients become disabled. In childhood, however, arthritis is uncommon and most children with the disease will emerge into adult life relatively unscathed, able to hold down a useful job and to run a home. Such a favourable outcome is directly related to years of scrupulous work and careful observation by workers such as Professor Eric Bywaters and Dr Barbara Ansell at Taplow Hospital. They achieve their good results not only by medication but also by expert physiotherapy with daily exercise regimens over many years. Individual splints and supports are made by specialist occupational therapists and the child is kept under regular review by Dr Ansell or, increasingly, at regional centres with access to Taplow. These centres may also serve as a source of local skill and support. It is because the numbers of affected children are small that this pyramidal structure can work well.
But what of adult disease ? Such a pyramidal organisation at national level is impracticable because of the large numbers of patients concerned. Theoretically, all patients should have ready access to a consultant rheumatologist at district level. There are enough senior registrars trained to provide such services but apparently there is insufficient money locally to fund the necessary posts. Inevitably, therefore, regional clinics are heavily overburdened. Indeed, some patients with chronic disease will never reach specialist care and most will have to wait many weeks before they are seen.
General practitioners, and their patients, may have a difficult decision to make: is referral worth while-and, if so, when ? It is equally difficult to know when rereferral is necessary in a group of diseases notable for their chronicity, unpredictability, and ability to produce frustration and restrict lifestyle.
Perhaps the most important question is the first. Scott and his colleagues have assessed the long term effects of treating rheumatoid arthritis, describing the results of the Droitwich study , in which patients were followed up for 10 years and given intensive treatment with non-steroidal antiinflammatory drugs and second line drugs. These patients were, by definition, severely affected. They concluded that adequate treatment may influence progression of the disease and that these patients needed treatment with second line drugs, usually gold or penicillamine. Furthermore, "the importance of admission to specialised rheumatic units in hospitals which provide a wide range of supportive and physical treatments cannot be overemphasised. These units should be provided by the Health Service. Even ifrheumatoid arthritis is not cured by treatment, its management requires long term commitment."' Zinn has also discussed the provision of long term care for patients with arthritis and suggests that "the task of the responsible doctor is usually to organise home, community and hospital treatment and to provide the necessary measures for 'prophylactic' as well as 'curative' rehabilitation ... it is difficult to achieve the best possible result without therefore having a full knowledge of the actual therapeutic and rehabilitative possibilities and their results."2
If we accept that referral to a specialist is worth while, the next question is when should referrals and rereferrals be made ? Firstly, any patient with joint disease which has persisted over three to six months should be referred for investigation, as should any patient whose job or home life is jeopardised by the disability. At present, it is almost impossible to find a middle aged or elderly disabled person a new job. The patient is thus best advised to remain in his current job for as long as possible, and it is part of the specialist's brief to consider the impact of the disease on the patient's work; Second line drugs and surgery may modify the disability but additional measures should also be considered, such as obtaining a mobility allowance, taking advantage of the Fares to Work scheme, and arranging for special modifications to the workplace.
Joint deformities should be treated vigorously. It is unacceptable to watch with equanimity while a patient loses his grip, when arthrodesis of the wrist provides an excellent, pain free solution to the weak and unstable wrist. The physician should also be alert to the patient who spends so much of her day in an armchair that she takes up its shape, with knees and hips held in permanent flexion. If such deformities become established it may be impossible to reverse them. At best, it takes weeks of expensive inpatient treatment.
Extra-articular disease, such as neuritis or vasculitis, usually bodes ill for the patient and is certainly a sufficient reason for referral and for second line treatment.
Many rheumatologists believe that second line treatment should begin early, when patients fail to respond to simple measures, when they remain generally ill, or if there is radiological evidence oferosions or joint destruction. Such patients are usually given gold or penicillamine. Because of the pressures on rheumatology outpatient departments and the long distances that some patients have to travel, general practitioners may be asked to monitor their own patients. This will entail obtaining a full blood picture and testing the urine for protein between hospital visits. If any side effects occur the patient should promptly be referred back to the rheumatologist.
The specific indications for referral may thus be summarised as the three D's: disease decline; deformity; and disability (with diminishing function).
Actors get despondent when after interview they hear the familiar words, "Don't call us, we'll call you." Many patients with chronic arthritis feel the same. But much can be done for them, even in the absence of specific cures for most arthropathies. Thus A great deal of information on drugs and their prescribing is now provided at a local level from the 200 or so drugs and therapeutics committees throughout Britain.' These are composed of senior medical, pharmacy, and nursing staff, whose primary terms of reference include the development of drug policies through local formularies or recommended lists, the achievement of economy and safety in the use of drugs, the provision of information on their costs and efficacy, and the monitoring of their use and expenditure.
The use of local formularies or limited lists is often said to restrict a doctor's freedom in prescribing and would, it is said, be generally resisted by British doctors. Experience among general practitioners and hospital doctors in many parts of Britain has shown, however, that many (and probably most) welcome positive guidance on which drugs in different groups should be considered the "best buy" for given conditions. Such guidance may be provided by drug information centres in response to specific inquiries or in the form of circulated notes, but the long experience of the late James Crooks in Tayside led him to the conclusion that the "economic and effective means of communication is through the production and adoption of local formularies."2
The success of a local formulary will depend on the extent to which there is a consensus among the doctors concerned to follow the recommendations; and this in turn usually depends on the extent to which local clinicians have been concerned in producing the recommended lists of drugs. The recommendations must have the confidence of local doctors, not only in hospitals but also in surrounding general practices, for one very important consequence of the circulation of a formulary is that it should lead to a uniformity of drug usage throughout a district-so simplifying the continuation of drug treatment when patients are admitted to, and discharged from, hospital.
Auditing 
